Among participants taking at least 80% of study capsules, the average Ki-67 expression in prostate tumor tissue was 3.00% in the intervention arm and 2.90% in the placebo arm (p = 0.94, Table 3). The gene discussed is MKI67; the disease is prostate neoplasm.